Maciel MM, López FJA, Ramos ÁG, López CA

Language: Spanish
References: 10
Page: 89-94
PDF size: 92.28 Kb.

ABSTRACT

Objective: To examine the efficacy and safety of oxitocin administered through umbilical vein after delivery to diminish the incidence of retained placenta, blood loss and third stage of labour.
Methodology: A double blind, clinical trial was performed in which 64 women in labour, any age, with normal pregnancies, with gestational time between 37 to 42 weeks, were randomized to one of two groups. Group 1 received 10 UI of oxitocin (2 mL) diluted in 18 mL of saline solution through umbilical vein, immediately after delivery. Group 2 received only 20 mL of saline solution. Blood loss, time of third stage of labour, retained placenta, nausea, vomit and arterial hypotension were measured.
Results: Blood loss was 263.7 ± 220.9 mL in group 1 (n=32) and 286.7 + 230.4 in group 2 (n=32) (p=0.68, Student T test). Time of third stage of labour was 265.3 ± 383.9 seconds in group 1 and 197.1 ± 314.3 in group 2 (p=0.44, Student T test). There was one retained placenta in group 1 and two in group 2 (RR 0.5 IC 0.04 a 5.24). There were not side effects in any group.
Conclusions: Oxitocin trough umbilical vein immediately after delivery was not useful to diminish blood loss, retained placenta or time of third stage of labour.

REFERENCES

1. Sepúlveda W. Management of total placental retention with oxytocin injected into umbilical vein. Rev Chil Obstet Ginecol 1991;56:111-3.

2. Hayman R, Arulkumaran S, Steer P. Uterine compression sutures: Surgical management of postpartum haemorrhage. Obstet Gynecol 2002;99:543-6.

3. Li X, Fortney J, Kotelchnuch M, Gloverltt LH. The postpartum period: The key to maternal mortality. Int J Gynaecol Obstet 1996;54:1-10.

4. Quadir K, IS J, Wani S. Controlled cord traction versus minimal intervention technique in delivery of the placenta: A randomized controlled trial. Am J Obstet Gynecol 1997;177:770-4.

5. Prendiville W, Elbourne D, McDonald S. Active versus expectant management the third stage of labour (Cochrane Review). In: The Cochrane Library 2. Oxford, Update software, 2001.

6. Wingerer R, Griggs R. Management of retained placenta vein intraumbilical oxytocin injection. Journal of Nurse Midwifery 1991;36:240-4.

7. Carroli G. Bergel E. Umbilical vein injection for management of retained placenta (Cochrane Review). In: The Cochrane Library, Oxford, Update software, 2001.

8. Chestnut DH, Wilcox LL. Influence of umbilical vein administration of oxitocin on the third stage of labour: A randomized, double-blind, placebo-controlled. Am J Obstet Gynecol 1987;157:160-2.

9. Young S, Martelly P, Greb L, Considine G, Coustan D. The effect of intraumbilical oxitocin on the third stage of labor. Obstet Gynecol 1988;71:736-8.

10. Wilken-Jensen C, Strom V, Nielsen M, Rosenkilde-Gram B. Removing a retained placenta by oxytocin. A controlled study. Am J Obstet Gynecol 1989;161:155-7.